[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P.A., Clarke M., Devereaux P.J., Kleijnen J., Moher D
Impressive A1c Lowering from Once-Weekly Semaglutide in Type 2 Diabetes By Emma Ryan A recent trial comparing once-weekly GLP-1 agonists semaglutide and Trulicity found improved A1c and double the weight loss with semaglutide We recently heard about results from the SUSTAIN 7 trial of semaglutide, a powerful once-weekly, injectable GLP-1 agonist that is currently under FDA review for type 2 diabetes
The choice of alternative depends on individual factors including glycaemic control, weight, cardiovascular risk, renal function, and patient preference
Practical Considerations for Use of Phentermine Dosing Strategies : Typical starting dose: 15-37.5 mg once daily in the morning Maximum recommended duration: 12 weeks for initial treatment (though some clinicians prescribe longer with careful monitoring) Should always be taken before breakfast or 1-2 hours after to maximize appetite suppression Patient Selection Criteria : BMI 30 kg/m Or BMI 27 kg/m with obesity-related comorbidities (hypertension, diabetes, dyslipidemia) Must be used as part of a comprehensive weight management program Adderall - Understanding Its Role and Limitations in Weight Management The Pharmacology of Adderall Adderall is a combination drug containing four amphetamine salts (75% dextroamphetamine and 25% levoamphetamine)
